Pharma-Bio Serv (PBSV) Revenue (2010 - 2026)

Pharma-Bio Serv's Revenue history runs 16 years deep, the most recent figure standing at $2.7 million for Q2 2026.

• Revenue for Q2 2026 came in at $2.7 million, up 11.83% year-over-year; the trailing twelve-month figure through Apr 2026 was $9.1 million (down 5.49% YoY), and the FY2025 annual result was $9.0 million, down 5.34% from the prior year.
• Revenue came in at $2.7 million for Q2 2026 at Pharma-Bio Serv, up from $2.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $5.0 million in Q1 2022 to a low of $2.0 million in Q3 2025.
• A 5-year average of $3.3 million and a median of $2.6 million in 2025 frame the typical range for Revenue.
• Across the five-year window, Revenue tumbled 47.9% in 2024 and grew 11.83% in 2026, its largest moves.
• Over 5 years, Revenue stood at $4.6 million in 2022, then retreated by 22.42% to $3.6 million in 2023, then plunged by 35.15% to $2.3 million in 2024, then slipped by 7.87% to $2.1 million in 2025, then grew by 25.74% to $2.7 million in 2026.
• The last three Revenue figures came in at $2.7 million (Q2 2026), $2.3 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.